De Raeve H - Search Results

1

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.

Maes A, Maes K, Vlummens P, De Raeve H, Devin J, Szablewski V, De Veirman K, Menu E, Moreaux J, Vanderkerken K, De Bruyne E. Maes A, et al. Among authors: de raeve h. Blood Cancer J. 2019 Nov 18;9(12):87. doi: 10.1038/s41408-019-0249-x. Blood Cancer J. 2019. PMID: 31740676 Free PMC article.

2

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.

Faict S, Muller J, De Veirman K, De Bruyne E, Maes K, Vrancken L, Heusschen R, De Raeve H, Schots R, Vanderkerken K, Caers J, Menu E. Faict S, et al. Among authors: de raeve h. Blood Cancer J. 2018 Nov 8;8(11):105. doi: 10.1038/s41408-018-0139-7. Blood Cancer J. 2018. PMID: 30409995 Free PMC article.

3

The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.

Maes A, Maes K, De Raeve H, De Smedt E, Vlummens P, Szablewski V, Devin J, Faict S, De Veirman K, Menu E, Offner F, Spaargaren M, Moreaux J, Vanderkerken K, Van Valckenborgh E, De Bruyne E. Maes A, et al. Among authors: de raeve h. Br J Cancer. 2019 Jun;120(12):1137-1146. doi: 10.1038/s41416-019-0471-0. Epub 2019 May 15. Br J Cancer. 2019. PMID: 31089208 Free PMC article.

4

Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion, and apoptosis.

Asosingh K, De Raeve H, Van Riet I, Van Camp B, Vanderkerken K. Asosingh K, et al. Among authors: de raeve h. Blood. 2003 Apr 15;101(8):3136-41. doi: 10.1182/blood-2002-10-3000. Epub 2002 Dec 12. Blood. 2003. PMID: 12480692 Free article.

5

Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity.

Asosingh K, De Raeve H, Menu E, Van Riet I, Van Marck E, Van Camp B, Vanderkerken K. Asosingh K, et al. Among authors: de raeve h. Blood. 2004 Apr 15;103(8):3131-7. doi: 10.1182/blood-2003-08-2946. Epub 2003 Nov 26. Blood. 2004. PMID: 15070695 Free article.

6

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.

Menu E, Jernberg-Wiklund H, Stromberg T, De Raeve H, Girnita L, Larsson O, Axelson M, Asosingh K, Nilsson K, Van Camp B, Vanderkerken K. Menu E, et al. Among authors: de raeve h. Blood. 2006 Jan 15;107(2):655-60. doi: 10.1182/blood-2005-01-0293. Epub 2005 Jul 26. Blood. 2006. PMID: 16046527 Free article.

7

Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.

Vanderkerken K, Medicherla S, Coulton L, De Raeve H, Willems A, Lawson M, Van Camp B, Protter AA, Higgins LS, Menu E, Croucher PI. Vanderkerken K, et al. Among authors: de raeve h. Cancer Res. 2007 May 15;67(10):4572-7. doi: 10.1158/0008-5472.CAN-06-4361. Epub 2007 May 10. Cancer Res. 2007. PMID: 17495322

8

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug.

Hu J, Handisides DR, Van Valckenborgh E, De Raeve H, Menu E, Vande Broek I, Liu Q, Sun JD, Van Camp B, Hart CP, Vanderkerken K. Hu J, et al. Among authors: de raeve h. Blood. 2010 Sep 2;116(9):1524-7. doi: 10.1182/blood-2010-02-269126. Epub 2010 Jun 7. Blood. 2010. PMID: 20530289 Free article.

9

Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro.

Hu J, Van Valckenborgh E, Xu D, Menu E, De Raeve H, De Bruyne E, Xu S, Van Camp B, Handisides D, Hart CP, Vanderkerken K. Hu J, et al. Among authors: de bruyne e, de raeve h. Mol Cancer Ther. 2013 Sep;12(9):1763-73. doi: 10.1158/1535-7163.MCT-13-0123. Epub 2013 Jul 5. Mol Cancer Ther. 2013. PMID: 23832122

10

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.

Maes K, De Smedt E, Lemaire M, De Raeve H, Menu E, Van Valckenborgh E, McClue S, Vanderkerken K, De Bruyne E. Maes K, et al. Among authors: de smedt e, de bruyne e, de raeve h. Oncotarget. 2014 May 30;5(10):3115-29. doi: 10.18632/oncotarget.1821. Oncotarget. 2014. PMID: 24833108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters